The American College of Rheumatology recommends biosimilar use in new white paper

The ACR has published a new white paper that provides a comprehensive overview of the scientific, clinical, economic and prescribing issues pertaining to biosimilar use. The paper encourages providers to incorporate these drugs into treatment plans of patients with rheumatic diseases.
Go to Source